Transmission and spreading of tauopathy in transgenic mouse brain

Cited by (1,006)

Items 201–300 of 1,006

1. Four-repeat tauopathies
   Thomas W. Rösler, Amir Tayaranian Marvian, Matthias Brendel, Niko-Petteri Nykänen, Matthias Höllerhage, Sigrid C. Schwarz, Franziska Hopfner, Thomas Koeglsperger, Gesine Respondek, Kerstin Schweyer et al. · 2019 · Progress in Neurobiology
2. Cellular and pathological heterogeneity of primary tauopathies
   Dah‐eun Chloe Chung, Shanu Faerch Roemer, Leonard Petrucelli, Dennis W. Dickson · 2021 · Molecular Neurodegeneration
3. Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation
   Mirbaha, Hilda, Holmes, Brandon B., Sanders, David W., Bieschke, Jan, Diamond, Marc I. · 2015 · Journal of Biological Chemistry
4. Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein
   Simon Dujardin, Séverine Bégard, Raphaëlle Caillierez, Cédrick Lachaud, Lucie Delattre, Sébastien Carrier, Anne Loyens, Marie‐Christine Galas, Luc Bousset, Ronald Melki et al. · 2014 · PLoS ONE
5. Are tau aggregates toxic or protective in tauopathies?
   Cowan, Catherine M., Mudher, Amrit · 2013 · Frontiers in Neurology
6. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice
   Peeraer, Eve, Bottelbergs, Astrid, Van Kolen, Kristof, Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Mahieu, Michel, Duytschaever, Hilde, Ver Donck, Luc, Torremans, An, Sluydts, Ellen et al. · 2015 · Neurobiology of Disease
7. Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
   Jiayi Li, Elisabet M. Englund, Håkan Widner, Stig Rehncrona, Anders Björklund, Olle Lindvall, Patrik Brundin · 2010 · Movement Disorders
8. Propagation of Tau aggregates
   Goedert, Michel, Spillantini, Maria Grazia · 2017 · Molecular Brain
9. Mouse Models of Alzheimer’s Disease
   Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke · 2022 · Frontiers in Molecular Neuroscience
10. The role of extracellular vesicles in neurodegenerative diseases
    Quek, Camelia, Hill, Andrew F. · 2017 · Biochemical and Biophysical Research Communications
11. Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)
    Rauch, Jennifer N., Chen, John J., Sorum, Alexander W., Miller, Gregory M., Sharf, Tal, See, Stephanie K., Hsieh-Wilson, Linda C., Kampmann, Martin, Kosik, Kenneth S. · 2018 · Scientific Reports
12. Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer’s Disease Genetics
    Podleśny-Drabiniok, Anna, Marcora, Edoardo, Goate, Alison M. · 2020 · Trends in Neurosciences
13. Transmissible Proteins: Expanding the Prion Heresy
    Claudio A. Soto · 2012 · Cell
14. Extracellular vesicles – Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases
    Coleman, Bradley M., Hill, Andrew F. · 2015 · Seminars in Cell & Developmental Biology
15. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes
    Scheiblich, Hannah, Eikens, Frederik, Wischhof, Lena, Opitz, Sabine, Jüngling, Kay, Cserép, Csaba, Schmidt, Susanne V., Lambertz, Jessica, Bellande, Tracy, Pósfai, Balázs et al. · 2024 · Neuron
16. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
    James A. R. Nicoll, George R. Buckland, Charlotte H. Harrison, Anton M. Page, Scott Harris, Seth Love, James Neal, Clive Holmes, Delphine Boche · 2019 · Brain
17. Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
    Ludovic Collin, Bernd Bohrmann, Ulrich Göpfert, Krisztina Oroszlan‐Szovik, Laurence Ozmen, Fiona Grüninger · 2014 · Brain
18. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer’s Disease
    Ashish Raj, Eve LoCastro, Amy F. Kuceyeski, Duygu Tosun, Norman R. Relkin, Michael Walter Weiner · 2015 · Cell Reports
19. Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
    McEwan, William A., Falcon, Benjamin, Vaysburd, Marina, Clift, Dean, Oblak, Adrian L., Ghetti, Bernardino, Goedert, Michel, James, Leo C. · 2017 · Proceedings of the National Academy of Sciences
20. Amyloid-β and Tau at the Crossroads of Alzheimer’s Disease
    Gilbert Gallardo, David M. Holtzman · 2019 · Advances in experimental medicine and biology
21. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau
    Taniguchi-Watanabe, Sayuri, Arai, Tetsuaki, Kametani, Fuyuki, Nonaka, Takashi, Masuda-Suzukake, Masami, Tarutani, Airi, Murayama, Shigeo, Saito, Yuko, Arima, Kunimasa, Yoshida, Mari et al. · 2016 · Acta Neuropathologica
22. Selective Vulnerability of Neurons in Layer II of the Entorhinal Cortex during Aging and Alzheimer's Disease
    Stranahan, Alexis M., Mattson, Mark P. · 2010 · Neural Plasticity
23. Traumatic Brain Injury Induces Tau Aggregation and Spreading
    Edwards, George, Zhao, Jing, Dash, Pramod K., Soto, Claudio, Moreno-Gonzalez, Ines · 2020 · Journal of Neurotrauma
24. Tau-Centric targets and drugs in clinical development for the treatment of alzheimer's disease
    Panza, Francesco, Solfrizzi, Vincenzo, Seripa, Davide, Imbimbo, Bruno P., Lozupone, Madia, Santamato, Andrea, Zecca, Chiara, Barulli, Maria Rosaria, Bellomo, Antonello, Pilotto, Alberto et al. · 2016 · BioMed Research International
25. Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
    Congdon, Erin E., Gu, Jiaping, Sait, Hameetha B.R., Sigurdsson, Einar M. · 2013 · Journal of Biological Chemistry
26. ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule‐associated proteins
    Amrita Ramkumar, Brigette Y Jong, Kassandra M Ori-McKenney · 2017 · Developmental Dynamics
27. Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
    Nadege Zommer, Nicolas Sergeant, Susanna Schraen-Maschke, David Blum, Luc Buee · 2012 · Current Alzheimer Research
28. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
    Blair, Laura J, Frauen, Haley D, Zhang, Bo, Nordhues, Bryce A, Bijan, Sara, Lin, Yen-Chi, Zamudio, Frank, Hernandez, Lidice D, Sabbagh, Jonathan J, Selenica, Maj-Linda B et al. · 2015 · Acta Neuropathologica Communications
29. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
    Vasconcelos, Bruno, Stancu, Ilie-Cosmin, Buist, Arjan, Bird, Matthew, Wang, Peng, Vanoosthuyse, Alexandre, Van Kolen, Kristof, Verheyen, An, Kienlen-Campard, Pascal, Octave, Jean-Noël et al. · 2016 · Acta Neuropathologica
30. De novo induction of amyloid-β deposition in vivo
    Rodrigo Morales, Claudia A. Duran-Aniotz, Joaquı́n Castilla, Lisbell D. Estrada, Claudio A. Soto · 2011 · Molecular Psychiatry
31. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
    Mathieu Bourdenx, Nikolaos Stavros Koulakiotis, Despina Sanoudou, Erwan Bézard, Benjamin Dehay, Anthony Tsarbopoulos · 2015 · Progress in Neurobiology
32. Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
    Yazi Diana Ke, Fabien Delerue, Amadeus Gladbach, Jürgen Götz, Lars Matthias Ittner · 2009 · PLoS ONE
33. Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
    Luis Daniel Bernal-Conde, Rodrigo Ramos-Acevedo, Mario A. Reyes-Hernández, Andrea Joselin Balbuena-Olvera, Ishbelt D. Morales-Moreno, Rubén Argüero‐Sánchez, Birgitt Schüle, Magdalena Guerra‐Crespo · 2020 · Frontiers in Neuroscience
34. Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability
    Flach, Katharina, Hilbrich, Isabel, Schiffmann, Andrea, Gärtner, Ulrich, Krüger, Martin, Leonhardt, Marion, Waschipky, Hanka, Wick, Lukas, Arendt, Thomas, Holzer, Max · 2012 · Journal of Biological Chemistry
35. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
    Colin, Morvane, Dujardin, Simon, Schraen-Maschke, Susanna, Meno-Tetang, Guy, Duyckaerts, Charles, Courade, Jean-Philippe, Buée, Luc · 2020 · Acta Neuropathologica
36. Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
    Carmen I. Nussbaum-Krammer, Mário F. Neto, Renée M. Brielmann, Jesper Søndergaard Pedersen, Richard I. Morimoto · 2015 · Journal of Visualized Experiments
37. Tau passive immunization inhibits not only tau but also Aβ pathology
    Chun‐Ling Dai, Yunn Chyn Tung, Fei Liu, Cheng‐Xin Gong, Khalid Iqbal · 2017 · Alzheimer s Research & Therapy
38. Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro
    Paul M. Seidler, Kevin A. Murray, David R. Boyer, Peng Ge, Michael R. Sawaya, Carolyn J. Hu, Xinyi Cheng, Romany N. N. Abskharon, Hope Pan, Michael A. Deture et al. · 2022 · Nature Communications
39. Targeting microglia for the treatment of Alzheimer’s Disease
    Wes, Paul D., Sayed, Faten A., Bard, Frédérique, Gan, Li · 2016 · Glia
40. Anti‐tau antibody reduces insoluble tau and decreases brain atrophy
    Yanamandra, Kiran, Jiang, Hong, Mahan, Thomas E., Maloney, Susan E., Wozniak, David F., Diamond, Marc I., Holtzman, David M. · 2015 · Annals of Clinical and Translational Neurology
41. Prion-like spread of protein aggregates in neurodegeneration
    Polymenidou, Magdalini, Cleveland, Don W. · 2012 · Journal of Experimental Medicine
42. Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology
    Toledo, Jon B., Gopal, Pallavi, Raible, Kevin, Irwin, David J., Brettschneider, Johannes, Sedor, Samantha, Waits, Kayla, Boluda, Susana, Grossman, Murray, Van Deerlin, Vivianna M. et al. · 2016 · Acta Neuropathologica
43. Amyloid assembly and disassembly
    Edward Chuang, Acacia M Hori, Christina D. Hesketh, James Shorter · 2018 · Journal of Cell Science
44. Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
    Paolo d’Errico, Melanie Meyer‐Luehmann · 2020 · Frontiers in Aging Neuroscience
45. Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives
    Seung‐Jae Lee, Hee-Sun Lim, Eliezer Masliah, He-Jin Lee · 2011 · Neuroscience Research
46. Motor Network Degeneration in Amyotrophic Lateral Sclerosis: A Structural and Functional Connectivity Study
    Esther Verstraete, Martijn P. van den Heuvel, Jan Herman Veldink, Niels Blanken, René C.W. Mandl, Hilleke E. Hulshoff Pol, Leonard H. van den Berg · 2010 · PLoS ONE
47. Beyond the prion principle
    Adriano Aguzzi · 2009 · Nature
48. Tau protein and tau aggregation inhibitors
    Bruno Bulic, Marcus Pickhardt, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2010 · Neuropharmacology
49. Cognition in corticobasal syndrome and progressive supranuclear palsy: A review
    James R. Burrell, John R. Hodges, James Benedict Rowe · 2014 · Movement Disorders
50. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody
    Marie Albert, Georges Mairet‐Coello, Clément Danis, Sarah Lieger, Raphaëlle Caillierez, Sébastien Carrier, Emilie Skrobala, Isabelle Landrieu, Anne Michel, Mathieu Schmitt et al. · 2019 · Brain
51. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
    Ferrer, Isidro · 2012 · Progress in Neurobiology
52. Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells
    Amanda L. Woerman, Atsushi Aoyagi, Smita S. Patel, Sabeen A. Kazmi, Iryna V. Lobach, Lea T. Grinberg, Ann Carolyn McKee, William W. Seeley, Steven H. Olson, Stanley B. Prusiner · 2016 · Proceedings of the National Academy of Sciences
53. Networks of tau distribution in Alzheimer’s disease
    Merle C. Hoenig, Gérard N. Bischof, Joseph Seemiller, Jochen Hammes, Juraj Kukolja, Oezguer A. Onur, Frank Jessen, Klaus Fließbach, Bernd Neumaier, Gereon R. Fink et al. · 2017 · Brain
54. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer’s disease
    Jin, Mengmeng, Xu, Ranjie, Wang, Le, Alam, Mahabub Maraj, Ma, Ziyuan, Zhu, Sining, Martini, Alessandra C., Jadali, Azadeh, Bernabucci, Matteo, Xie, Ping et al. · 2022 · Cell Stem Cell
55. Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies
    Celeste M M. Karch, Amanda T. Jeng, Alison Goate · 2012 · Journal of Biological Chemistry
56. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading
    Xu, Yin, Propson, Nicholas E., Du, Shuqi, Xiong, Wen, Zheng, Hui · 2021 · Proceedings of the National Academy of Sciences
57. Intercellular (Mis)communication in Neurodegenerative Disease
    Gwenn A. Garden, Albert R. La Spada · 2012 · Neuron
58. Nonhuman Primate Models of Alzheimer-Like Cerebral Proteopathy
    Heuer, Eric, F. Rosen, Rebecca, Cintron, Amarallys, C. Walker, Lary · 2012 · Current Pharmaceutical Design
59. The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
    Dourlen, Pierre, Kilinc, Devrim, Malmanche, Nicolas, Chapuis, Julien, Lambert, Jean-Charles · 2019 · Acta Neuropathologica
60. Prion hypothesis: the end of the controversy?
    Claudio A. Soto · 2010 · Trends in Biochemical Sciences
61. Evaluation of Potential Infectivity of Alzheimer and Parkinson Disease Proteins in Recipients of Cadaver-Derived Human Growth Hormone
    David John Irwin, Joseph Y. Abrams, Lawrence B. Schonberger, Ellen Leschek, James L. Mills, Virginia M.‐Y. Lee, John Q. Trojanowski · 2013 · JAMA Neurology
62. Tau and Tauopathies
    Gloria S. Lee, Chad J. Leugers · 2012 · Progress in molecular biology and translational science
63. Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology
    Michel, Claire H., Kumar, Satish, Pinotsi, Dorothea, Tunnacliffe, Alan, St. George-Hyslop, Peter, Mandelkow, Eckhard, Mandelkow, Eva-Maria, Kaminski, Clemens F., Kaminski Schierle, Gabriele S. · 2014 · Journal of Biological Chemistry
64. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
    Jinsoo Seo, Oleg Kritskiy, Lauren Ashley Watson, Scarlett J. Barker, Dilip Chandra Dey, Waseem Khan Raja, Yuan-Ta Lin, Tak Ko, Sukhee Cho, Jay Penney et al. · 2017 · Journal of Neuroscience
65. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
    Chao Peng, Ronald J. Gathagan, Virginia M.‐Y. Lee · 2017 · Neurobiology of Disease
66. Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
    Jiaping Gu, Erin E. Congdon, Einar M. Sigurdsson · 2013 · Journal of Biological Chemistry
67. Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
    Michel Brahic, Luc Bousset, Gregor Bieri, Ronald Melki, Aaron D. Gitler · 2016 · Acta Neuropathologica
68. Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
    Dominic M. Walsh, Dennis J. Selkoe · 2020 · Current Opinion in Neurobiology
69. C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death
    Daniel Kanmert, Adam Cantlon, Christina Muratore, Ming Jin, Tiernan T. O’Malley, Gloria S. Lee, Tracy L. Young‐Pearse, Dennis J. Selkoe, Dominic M. Walsh · 2015 · Journal of Neuroscience
70. Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
    Anne Eckert, Kathrin L. Schulz, Virginie F. Rhein, Jürgen Götz · 2010 · Molecular Neurobiology
71. Amyloidogenesis of Tau protein
    Bartosz Niżyński, Wojciech Dzwolak, Krzysztof Nieznański · 2017 · Protein Science
72. Invited review: Prion‐like transmission and spreading of tau pathology
    Clavaguera, Florence, Hench, Jürgen, Goedert, Michel, Tolnay, Markus · 2015 · Neuropathology and Applied Neurobiology
73. A deadly spread: cellular mechanisms of α-synuclein transfer
    Jennifer A. Steiner, Élodie Angot, Patrik Brundin · 2011 · Cell Death and Differentiation
74. Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
    Marianna D’Anca, Chiara Fenoglio, María Serpente, Beatrice Arosio, Matteo Cesari, Elio Angelo Scarpini, Daniela Galimberti · 2019 · Frontiers in Aging Neuroscience
75. Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
    Steven Samuel Plotkin, Neil R. Cashman · 2020 · Neurobiology of Disease
76. Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
    Park, Jun Sung, Lee, Junehawk, Jung, Eun Sun, Kim, Myeong-Heui, Kim, Il Bin, Son, Hyeonju, Kim, Sangwoo, Kim, Sanghyeon, Park, Young Mok, Mook-Jung, Inhee et al. · 2019 · Nature Communications
77. Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular Tau
    Miguel Dı́az-Hernández, Alberto Gómez‐Ramos, Alicia Rubio, Rosa Gómez‐Villafuertes, José R. Naranjo, M. Teresa Miras‐Portugal, Jesús Ávila · 2010 · Journal of Biological Chemistry
78. Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
    Bi, Mian, Ittner, Arne, Ke, Yazi D., Götz, Jürgen, Ittner, Lars M. · 2011 · PLoS ONE
79. Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau
    Samuel J. Jackson, Caroline Kerridge, Jane Cooper, Annalisa Cavallini, Benjamin Falcon, Claire V. Cella, Alessia Landi, Philip G. Szekeres, Tracey K. Murray, Zeshan Ahmed et al. · 2016 · Journal of Neuroscience
80. Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease
    Sundaram, Saranya, Hughes, Rachel L., Peterson, Eric, Müller-Oehring, Eva M., Brontë-Stewart, Helen M., Poston, Kathleen L., Faerman, Afik, Bhowmick, Chloe, Schulte, Tilman · 2019 · Neuroscience & Biobehavioral Reviews
81. Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance
    Jakob Domert, Sahana Bhima Rao, Lotta Agholme, Ann‐Christin Brorsson, Jan O. Marcusson, Martin Hallbeck, Sangeeta Nath · 2014 · Neurobiology of Disease
82. Can Infections Cause Alzheimer's Disease?
    Francis Mawanda, Robert B. Wallace · 2013 · Epidemiologic Reviews
83. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration
    Maddalena Costanzo, Chiara Zurzolo · 2013 · Biochemical Journal
84. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases
    Guiliana Soraya Victoria, Chiara Zurzolo · 2017 · The Journal of Cell Biology
85. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways
    Jacob I. Ayers, Susan Fromholt, Veronica O’Neal, Jeffrey Diamond, David Borchelt · 2015 · Acta Neuropathologica
86. Spreading of Tau Pathology in Sporadic Alzheimer’s Disease Along Cortico-cortical Top-Down Connections
    Braak, Heiko, Del Tredici, Kelly · 2018 · Cerebral Cortex
87. Rapid Accumulation of Endogenous Tau Oligomers in a Rat Model of Traumatic Brain Injury
    Bridget E. Hawkins, Shashirekha Krishnamurthy, Diana Laura Castillo‐Carranza, Urmi Sengupta, Donald S. Prough, George R. Jackson, Douglas S. DeWitt, Rakez Kayed · 2013 · Journal of Biological Chemistry
88. SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy
    Sang‐Won Min, Peter Sohn, Yaqiao Li, Nino Devidze, Jeffrey R. Johnson, Nevan J. Krogan, Eliezer Masliah, Sue‐Ann Mok, Jason E. Gestwicki, Li Gan · 2018 · Journal of Neuroscience
89. Frontotemporal Dementia: Implications for Understanding Alzheimer Disease
    Michel Goedert, Bernardino Francesco Ghetti, M. G. Spillantini · 2011 · Cold Spring Harbor Perspectives in Medicine
90. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
    Ronald Melki · 2015 · Journal of Parkinson s Disease
91. Invited Review: The role of prion‐like mechanisms in neurodegenerative diseases
    Zane Jaunmuktane, Sebastian Brandner · 2019 · Neuropathology and Applied Neurobiology
92. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review
    Mark John Millan · 2017 · Progress in Neurobiology
93. The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin
    Douglas G. Peters, James R. Connor, Mark D. Meadowcroft · 2015 · Neurobiology of Disease
94. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
    Roy O. Weller, Stephen Preston, Malavika Subash, Roxana Octavia Carare · 2009 · Alzheimer s Research & Therapy
95. Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies
    Michel Goedert, Ben Falcon, Florence Clavaguera, Markus Tolnay · 2014 · Current Neurology and Neuroscience Reports
96. Mapping interactions with the chaperone network reveals factors that protect against tau aggregation
    Sue‐Ann Mok, Carlo Condello, Rebecca Freilich, Anne T. Gillies, Taylor Arhar, Javier Oroz, Harindranath Kadavath, Olivier Julien, Victoria A. Assimon, Jennifer N. Rauch et al. · 2018 · Nature Structural & Molecular Biology
97. Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
    Atsuko Katsumoto, Hideyuki Takeuchi, Fumiaki Tanaka · 2019 · Frontiers in Neurology
98. The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
    Sarah Buchholz, Hans Zempel · 2024 · Alzheimer s & Dementia
99. Experimental evidence for the age dependence of tau protein spread in the brain
    Wegmann, Susanne, Bennett, Rachel E., Delorme, Louis, Robbins, Ashley B., Hu, Miwei, MacKenzie, Danny, Kirk, Molly J., Schiantarelli, Julia, Tunio, Nahel, Amaral, Ana C. et al. · 2019 · Science Advances
100. Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
     d’Abramo, Cristina, Acker, Christopher M., Jimenez, Heidy T., Davies, Peter · 2013 · PLoS ONE